Meprocon en es it fr

Meprocon Brand names, Meprocon Analogs

Meprocon Brand Names Mixture

  • No information avaliable

Meprocon Chemical_Formula


Meprocon RX_link

Meprocon fda sheet

Meprocon msds (material safety sheet)

Meprocon Synthesis Reference

Berger, Ludwig, U.S. Pat. 2,937,119 (1960)

Meprocon Molecular Weight

260.33 g/mol

Meprocon Melting Point

92-93 oC

Meprocon H2O Solubility

0.3 mg/ml

Meprocon State


Meprocon LogP


Meprocon Dosage Forms


Meprocon Indication

For the relief of discomfort associated with acute, painful, musculoskeletal conditions.

Meprocon Pharmacology

Carisoprodol is used as a skeletal muscle relaxant. One of its metabolites, meprobamate, is available as an anxiolytic agent.

Meprocon Absorption

No information avaliable

Meprocon side effects and Toxicity

Symptoms of overdose include drowsiness, giddiness, nausea, indigestion, or rash. Other adverse effects attributed to therapeutic use of carisoprodol include dizziness, irritability, insomnia, diplopia, temporary loss of vision, ataxia, weakness, headache, and dysarthria. Non-CNS adverse effects include gastrointestinal complaints, tachycardia, and postural hypotension. Patients sensitive to sulfites or tartrazine may experience wheezing, allergic rashes including erythema multiforme, or anaphylaxis after using some preparations of carisoprodol which contain such additives

Meprocon Patient Information

Carisoprodol is a muscle relaxant used to relieve the pain and stiffness of muscle spasms and discomfort due to strain and sprain. Inform your physician if you are pregnant or nursing. Do not take this medication with a monoamine oxidase inhibitor. This medication may cause dizziness, drowsiness, or blurred vision; use caution while driving or operating hazardous machinery. Do not take any other sedating drugs or drink alcohol while taking carisoprodol. If dizziness occurs, avoid sudden changes in posture. Take this medication with food to avoid stomach upset. Notify your physician if you develop trouble breathing, unexplained fever, severe weakness, vision changes, swelling, or skin rash. Withdrawal symptoms may occur if therapy is suddenly stopped in a patient on long-term or high-dose therapy.

Meprocon Organisms Affected

Humans and other mammals